Induction of apoptotic or lytic death in an ovarian adenocarcinoma cell line by antibodies generated against a synthetic N-terminal extracellular domain gonadotropin-releasing hormone receptor peptide

Acien, 1992, Embryological observations on the female genital tract, Hum. Reprod., 7, 437, 10.1093/oxfordjournals.humrep.a137666 Balasch, 1993, Follicular stimulation and ovarian cancer, Hum. Reprod., 8, 990, 10.1093/oxfordjournals.humrep.a138215 Chi, 1993, Cloning and characterization of the human GnRH receptor, Mol. Cell. Endocrinol., 91, R1, 10.1016/0303-7207(93)90278-R Conn, 1991, Gonadotropin-releasing hormone and its analogues, N. Engl. J. Med., 324, 93, 10.1056/NEJM199101103240205 Curnow, 1993, The role of apoptosis in antibody-dependent cellular cytotoxicity, Cancer Immunol. Immunother., 36, 149, 10.1007/BF01741085 Duke, 1992, Morphological and biochemical assays of apoptosis, 3.17.1 Eidne, 1992, Molecular cloning and characterization of the rat pituitary gonadotropin-releasing hormone (GnRH) receptor, Mol. Cell. Endocrinol., 90, R5, 10.1016/0303-7207(92)90116-N Emons, 1992, Intracellular actions of gonadotropic and peptide hormones and the therapeutic value of GnRH-agonists in ovarian cancer, Acta Obstet. Gynecol. Scand. Suppl., 155, 31, 10.1111/j.1600-0412.1992.tb00005.x Emons, 1992, LH RH agonists in the treatment of ovarian cancer, Rec. Results Cancer Res., 124, 55, 10.1007/978-88-470-2186-0_6 Garcia de Palazzo, 1993, Expression of mutated epidermal growth factor receptor by non-small cell lung earcinomas, Cancer Res., 53, 3217 Godwin, 1993, The biology of ovarian cancer development, Cancer, 71, 530, 10.1002/cncr.2820710207 Hamilton, 1992, Ovarian cancer, biology, Curr. Probl. Cancer, 16, 5, 10.1016/0147-0272(92)90047-R Harlow, 1988, Antibodies Hickman, 1992, Apoptosis induced by anticancer drugs, Cancer Metast. Rev., 11, 121, 10.1007/BF00048059 Kakar, 1992, Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor, Biochem. Biophys. Res. Commun., 189, 289, 10.1016/0006-291X(92)91556-6 Markman, 1993 Meyaard, 1992, Programmed death of T cells in HIV-1 infection, Science, 257, 217, 10.1126/science.1352911 Mortel, 1986, Inhibitory effect of GnRH superagonist on the growth of human ovarian carcinoma NIH:OVCAR-3 in the nude mouse, Gynecol. Oncol., 23, 254, 10.1016/0090-8258(86)90258-1 Perrin, 1993, Molecular and functional characterization of GnRH receptors cloned from rat pituitary and a mouse pituitary tumor cell line, Biochem. Biophys. Res. Commun., 191, 1139, 10.1006/bbrc.1993.1335 Ramanath, 1991, Endocrine factors in common epithelial ovarian cancer, Endocrinol. Rev., 12, 14, 10.1210/edrv-12-1-14 Rubin, 1993, Monoclonal antibodies in the management of ovarian cancer, Cancer, 71, 1602, 10.1002/cncr.2820710427 Schwartzman, 1993, Apoptosis: the biochemistry and molecular biology of programmed cell death, Endocrinol. Rev., 14, 133 Sherwood, 1993, Origin of mammalian gonadotropin-releasing hormones, Endocrinol. Rev., 14, 241, 10.1210/edrv-14-2-241 Trauth, 1989, Monoclonal antibody-mediated tumor regression by induction of apoptosis, Science, 245, 301, 10.1126/science.2787530 Tsutsumi, 1992, Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor, Mol. Endocrinol., 6, 1163, 10.1210/me.6.7.1163 Williams, 1991, Programmed cell death: apoptosis and oncogenesis, Cell, 65, 1097, 10.1016/0092-8674(91)90002-G Wyllie, 1992, Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview, Cancer Metast. Rev., 11, 95, 10.1007/BF00048057 Zychlinsky, 1988, Cytolytic mechanisms of the immune system, Curr. Opin. Immunol., 1, 63, 10.1016/0952-7915(88)90052-0